The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients

We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.

Detalles Bibliográficos
Autores principales: Ayers, Brian, Wood, Katherine, Falvey, Jennifer, Bernstein, Wendy, Gosev, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495745/
https://www.ncbi.nlm.nih.gov/pubmed/32983485
http://dx.doi.org/10.1002/ccr3.2967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495745/
https://www.ncbi.nlm.nih.gov/pubmed/32983485
http://dx.doi.org/10.1002/ccr3.2967

Ejemplares similares